Call Us08037400111
Buparvaquone Powder

Buparvaquone Powder

25.00 - 50.00 INR/Kilograms

Product Details:

  • Shelf Life 12 Months
  • Smell No Smell
  • Purity(%) 100%
  • Physical Form Powder
  • Supply Ability : 1000 Kilograms Per Day
  • Click to view more

Price And Quantity

  • 50 Kilograms
  • 25.00 - 50.00 INR/Kilograms

Product Specifications

  • Powder
  • No Smell
  • 12 Months
  • 100%

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Our company, Shreeji Pharma International, is a leading manufacturer of buparvaquone in Gujarat. India. WeThe professionals manufacture products under a GMP site with full regulatory support. It is a hydroxynaphthoquinone antiprotozoal similar to parvaquone and atovaquone. It is a promising compound for the therapy and prophylaxis of all kinds of theileriosis. It has been shown that buparvaquone has anti-leishmanial activity in vitro. As of today, Shreeji Pharma International exports Buparvaquone to countries in the Gulf, South East Asia, Africa, CIS, LATAM, Central America and Europe.


  • Name: Buparvaquone
  • CAS No.: 88426-33-9
  • Formula: C21H26O3
  • Molecular Weight: 326.43
  • Synonyms: 2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthochinon;1,4-Naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy-;Buparvaquone [BAN:INN];4-hydroxy-3-[(4-tert-butylcyclohexyl)methyl]naphthalene-1,2-dione;Buparvacuona [Spanish];Butalex;BW 720C; 2-((4-(1,1-Dimethylethyl)cyclohexyl)methyl)-3-hydroxy-1,4-naphthalenedione;2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone;(RS,RS,RS,RS)-2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone;Buparvaquonum [Latin];
  • Density: 1.158 g/cm3
  • Melting Point: 178-184 C
  • Boiling Point: 460.687 C at 760 mmHg
  • Flash Point: 246.536 C
  • Appearance: Yellow crystalline solid

How does it work?

It is currently being evaluated for use in treatment and prophylaxis of theileriosis. In vitro, buparvaquone is anti-leishmanial. Along with other known substances, it can treat bovine East Coast fever protozoa in vitro.

Manufacturing process:

A preparation method for buparvaquone is disclosed in the invention, which relates to medicine synthesis. Preparation involves: starting with 1,4-benzopyran diketone and p-tert-butylcyclohexyl acetaldehyde, then performing condensation and rearrangement to produce pharmaceutical grade buparvaquone. Buparvaquone can be prepared using the invention without using an expensive catalyst, and its synthesis yield is increased by approximately 65% compared to prior art. Additionally, the route is environment-friendly and industrially feasible.

How to use:

A veterinarian should administer injections of buparvaquone into the neck muscles. If it is severe, the treatment can be repeated every 48 to 72 hours. At the injection site, administer only 10 ml per injection.

Side effects:

Sometimes, thin-skinned animals may develop localized, painless, edematous swelling points at the injection site.

Warnings and precautions while using this product

Breathing mist or vapors is not recommended. Do not swallow them. Avoid getting them in your eyes. After handling, wash your skin thoroughly.


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Active Pharmaceuticals Ingredients (API)' category